Subcutaneous immunoglobulin as maintenance therapy for autoimmune autonomic ganglionopathy

Acta Neurol Belg. 2024 Jun;124(3):1099-1101. doi: 10.1007/s13760-023-02461-1. Epub 2023 Dec 22.

Authors

Elisabeth Chroni¹, Dimitra Veltsista², John Tzartos³, Eleftherios Triantafyllou², Zinovia Kefalopoulou²

Affiliations

¹ Department of Neurology, Medical School, University of Patras, 26504, Rio-Patras, Greece. echroni@yahoo.com.
² Department of Neurology, Medical School, University of Patras, 26504, Rio-Patras, Greece.
³ Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

PMID: 38133851
DOI: 10.1007/s13760-023-02461-1

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Adult
Autoimmune Diseases / drug therapy
Autoimmune Diseases / immunology
Autoimmune Diseases of the Nervous System* / drug therapy
Autoimmune Diseases of the Nervous System* / immunology
Autonomic Nervous System Diseases / drug therapy
Female
Ganglia, Autonomic / immunology
Humans
Immunoglobulins / administration & dosage
Immunoglobulins / therapeutic use
Immunologic Factors / therapeutic use
Injections, Subcutaneous
Male
Middle Aged

Substances

Immunoglobulins
Immunologic Factors